share_log

SVB Leerink Maintains Outperform on Replimune Group, Lowers Price Target to $30

SVB Leerink Maintains Outperform on Replimune Group, Lowers Price Target to $30

SVB Leerink维持Replimune集团的跑赢大盘,将目标股价下调至30美元
Benzinga Real-time News ·  2022/10/03 06:22

SVB Leerink analyst Jonathan Chang maintains Replimune Group (NASDAQ:REPL) with a Outperform and lowers the price target from $37 to $30.

SVB Leerink分析师乔纳森·张维持Replimune集团(纳斯达克股票代码:REPL)的股价跑赢大盘,并将目标股价从37美元下调至30美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发